Contract drug maker Catalent Inc. is expanding its US production of Moderna Inc.’s Covid-19 vaccine, a development that could ensure the US has ample supply as vaccines ramp up. Catalent has reached …
Read More »US stocks open higher on signs of an economic rebound
US equity futures rose on Monday after a strong employment report and before new data expected to show a recovery in the US services sector. Futures linked to the S&P 500 rose …
Read More »The intertwined empires of Greensill and Gupta had raised concerns internally for years
The business empires of metals magnate Sanjeev Gupta and financier Lex Greensill supported each other to fuel their growth. But for years executives and close advisers to both entrepreneurs urged the two …
Read More »GM turns to NBA executive Meg Whitman for board
General Motors Co. has appointed two new directors, including tech industry veteran Meg Whitman, its first high-profile move since the collapse last year of its media startup Quibi Holdings LLC. GM said …
Read More »Loyalty plans to launch Bitcoin ETFs
Fidelity Investments unveiled plans on Wednesday to launch an exchange-traded fund that tracks the price of bitcoin, fueling the money manager’s push to bring cryptocurrencies into mainstream finance. The ETF, called the …
Read More »KFC, Taco Bell and Pizza Hut to begin receiving text message orders
KFC owner Yum Brands Inc. is buying an Israel-based startup that helps customers order food to text, a strategy executives hope will boost sales as people leave the store. fast food and …
Read More »The consequences of AstraZeneca Data Snafu could be bigger than it seems
AstraZeneca’s vaccine data flap is unlikely to cost the company much, at least in the short term. Wall Street should pay close attention anyway. US officials said they were told that AstraZeneca …
Read More »AstraZeneca’s Covid-19 vaccine is safe and 79% effective in late-stage trials in the US.
AstraZeneca AZN -0.24% PLC’s Covid-19 vaccine was shown to be safe and 79% effective in preventing symptomatic diseases in US clinical trials involving more than 32,000 people, the British pharmacist said Monday. …
Read More »US COVID-19 Vaccine Production Dramatically Accelerates
Manufacturers of the COVID-19 vaccine are ramping up production, churning out far more doses a week than at the beginning of the year, progress that is accelerating mass vaccination campaigns in the …
Read More »Covid-19 Vaccine Manufacturing in the US Moves Forward
Covid-19 vaccine manufacturers are ramping up production, churning out far more doses a week than at the beginning of the year, progress that is accelerating mass vaccination campaigns in the US. After …
Read More »